Dexcom (DXCM) revenue: $4.7B
Dexcom reported $4.7B of revenue for the year ended Dec 31, 2025, up 15.6% from $4B a year earlier.
From Dexcom's filings with the SEC · Read the filing · DXCM stock page
Dexcom revenue by year
#745 of 3,622 US companies by revenue · See the full ranking
| Year ended | Revenue | Change |
|---|---|---|
| Dec 31, 2025 | $4.7B | +16% |
| Dec 31, 2024 | $4B | +11% |
| Dec 31, 2023 | $3.6B | +24% |
| Dec 31, 2022 | $2.9B | +19% |
| Dec 31, 2021 | $2.4B | – |
Revenue of similar companies
Companies in the same industry as Dexcom, by SEC industry code, with the closest revenue. Each name opens the same page for that company.
| Company | Revenue, latest year | Year ended |
|---|---|---|
| Solventum | $8.3B | Dec 31, 2025 |
| Resmed | $5.7B | Jun 30, 2026 |
| Dexcom | $4.7B | Dec 31, 2025 |
| MiniMed Group | $3.1B | Apr 24, 2026 |
| West Pharmaceutical Services | $3.1B | Dec 31, 2025 |
| Globus Medical | $2.9B | Dec 31, 2025 |
| Insulet | $2.7B | Dec 31, 2025 |
Questions and answers
What is Dexcom's revenue?
Dexcom reported $4.7B of revenue for the year ended Dec 31, 2025, up 15.6% from $4B a year earlier.
Numbers as reported in Dexcom's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology